Table 3.
Quantitative outcome parameters oesophageal and gastric cancer according to the probability of receiving treatment with curative intent
| Oesophageal cancer probabiliy | Gastric cancer probability | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Low | Middle | High | p value low versus high | p value middle versus high | Low | Middle | High | p value low versus high | p value middle versus high | |||||||
| Total | 477 | 100% | 548 | 100% | 625 | 100% | 516 | 333 | 560 | |||||||
| PET-CT | 347 | 73% | 425 | 78% | 458 | 73% | 0.84 | 0.09 | 103 | 20% | 44 | 13% | 114 | 21% | 0.81 | < 0.01 |
| EUS | 229 | 49% | 266 | 49% | 293 | 47% | 0.71 | 0.57 | 70 | 14% | 37 | 11% | 69 | 13% | 0.58 | 0.56 |
| DLS | NA | NA | NA | 91 | 18% | 66 | 20% | 94 | 17% | 0.77 | 0.28 | |||||
| Prior to MDTM | ||||||||||||||||
| Radiation oncologist | 233 | 47% | 263 | 48% | 329 | 53% | 0.053 | 0.11 | 9 | 2% | 7 | 2% | 12 | 2% | 0.62 | 0.95 |
| Medical oncologist | 305 | 64% | 324 | 59% | 401 | 64% | 0.94 | 0.08 | 293 | 58% | 189 | 58% | 316 | 58% | 0.95 | 0.96 |
| Surgeon | 259 | 54% | 301 | 55% | 393 | 63% | < 0.01 | < 0.01 | 311 | 61% | 198 | 61% | 374 | 69% | 0.01 | 0.02 |
| Multidisciplinaryb | 193 | 40% | 250 | 46% | 310 | 50% | 0.003 | 0.173 | 249 | 495 | 155 | 47% | 266 | 49% | 0.92 | 0.69 |
| Geriatrician prior to MDTM | 33 | 7% | 24 | 4% | 20 | 3% | < 0.01 | 0.29 | 56 | 11% | 20 | 6% | 66 | 12% | 0.59 | < 0.01 |
| Geriatrician prior to MDTM according to age groups | ||||||||||||||||
| < 70 years | 7 | 58% | 1 | 8% | 4 | 33% | 0.10* | 0.22 | 2 | 29% | 1 | 14% | 4 | 57% | 0.26 | 0.27* |
| 70—74 | 14 | 52% | 8 | 20% | 5 | 19% | < 0.01 | 0.41 | 11 | 48% | 4 | 17% | 8 | 35% | 0.37 | 0.23* |
| 75—80 | 10 | 36% | 10 | 36% | 8 | 29% | 0.31 | 0.58 | 20 | 39% | 5 | 10% | 26 | 51% | 0.55 | 0.02 |
| > 80 | 2 | 20% | 5 | 50% | 3 | 30% | 0.35* | 0.24* | 23 | 38% | 10 | 16% | 28 | 46% | 0.52 | 0.1 |
| Number of patients treated with neoadjuvant therapy | 184 | 263 | 316 | 171 | 125 | 192 | ||||||||||
| Restaging CT | 36 | 20% | 71 | 27% | 82 | 26% | < 0.01 | 0.7 | 115 | 67% | 79 | 63% | 115 | 60% | 0.58 | 0.61 |
| Restaging PET-CT | 98 | 53% | 88 | 33% | 145 | 46% | 0.45 | < 0.01 | 5 | 3% | 9 | 7% | 10 | 5% | 0.12 | 0.36 |
*Fishers exact test
bMultidisciplinary for esophageal cancer is defined as: radiation oncologist, medical oncologist and surgeon. For gastric cancer multidisciplinary is defined as medical oncologist and surgeon